The U.S. Food and Drug Administration (FDA) has granted Biogen’s investigational drug, litifilimab, Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus (CLE).

In this episode of the Lupus Foundation of America's The Expert Series podcast, we focus on the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus ...

Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.

We were joined experts who shared expert insights, practical tips, and personal experiences to empower patients to build ...

The Lupus Foundation of America has partnered with Carebox, the leading software platform for clinical trial patient recruitment, to launch the Lupus Clinical Trial Finder, a free platform available ...

The U.S. House of Representatives has voted to increase funding for lupus programs across the federal government, a huge victory for the lupus community and lupus advocates nationwide. Congress ...

In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen autoimmune skin conditions, such as in people with cutaneous lupus erythematosus ...

Empowerment Conference The Lupus & You: Empowerment conference is an experience that celebrates, inspires, supports, and uplifts lupus warriors, care partners, family, and friends. During this ...

Both subacute cutaneous lupus and discoid lupus are a form of lupus skin disease, though they have some distinct differences. Subacute cutaneous lupus may show up as ring-shaped red, scaly lesions.

­La nefritis lúpica es una de las complicaciones más graves del lupus eritematoso sistémico (LES). La nefritis lúpica se produce cuando el sistema inmune ataca ...